Recruiting

Enhanced Telehealth

Sponsor:

Memorial Sloan Kettering Cancer Center

Code:

NCT06954337

Conditions

Breast Cancer

Prostate Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Usual practice pattern (UPP)

Experimental: Enhanced Telehealth (ET)

Study Details

Brief summary:

Many people with cancer spend a lot of time and money traveling to and from the doctor's office for cancer care. MSK's goal is to make getting cancer care easier by cutting down the need to make in-person visits to MSK. MSK is trying to do this through a new option called enhanced telehealth.

Conditions

Breast Cancer

Prostate Cancer

Study ID

NCT06954337

Start date

May 1, 2025

Status verified date

Jul, 2026

Completion date

May 1, 2027

Anticipated

Primary completion date

Mar 1, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Patients with breast or prostate cancer at Memorial Sloan Kettering Cancer Center who have had at least 3 prior medical oncology visits.

Exclusion Criteria:

  • Patient is enrolled on a therapeutic clinical trial.
  • Patients whose primary language is not currently supported by Epic.

Study Design

Enrollment

1750 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

active comparator: Usual practice pattern (UPP)

Usual practice pattern (UPP) of patient's medical oncologist

experimental: Enhanced Telehealth (ET)

Enhanced Telehealth (ET) practice pattern of patient's medical oncologist

Interventions

Usual practice pattern (UPP)

Patient follows usual practice pattern for routine care

Experimental: Enhanced Telehealth (ET)

Patient follows enhanced telehealth practice pattern. As clinically appropriate, patients given option to shift routine care from face-to-face to at-home services available at institution: telehealth visits, home phlebotomy, and educational support for home administration of injection medications

Primary outcome measure

  • Proportion of routine face to face medical oncology related visits out of total medical oncology related visits [ Time Frame: 12 months ]

Central Contacts and Locations

Central contacts

Erin Bange, MD, MSCE

646-422-4680bangee@mskcc.org

Deborah Schrag, MD, MPH

212-639-5851

Locations

Memorial Sloan Kettering Basking Ridge (All Protocol Activities)

Recruiting

Basking Ridge, New Jersey, United States, 07920

Contacts

Erin Bange, MD, MSCE

646-422-4680

Memorial Sloan Kettering Monmouth (All Protocol Activities)

Recruiting

Middletown, New Jersey, United States, 07748

Contacts

Erin Bange, MD, MSCE

646-422-4680

Memorial Sloan Kettering Bergen (All Protocol Activities)

Recruiting

Montvale, New Jersey, United States, 07645

Contacts

Erin Bange, MD, MSCE

646-422-4680

Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities)

Recruiting

Commack, New York, United States, 11725

Contacts

Erin Bange, MD, MSCE

646-422-4680

Memorial Sloan Kettering Westchester (All Protocol Activities)

Recruiting

Harrison, New York, United States, 10604

Contacts

Erin Bange, MD, MSCE

646-422-4680

Memorial Sloan Kettering Cancer Center (All Protocol Activites)

Recruiting

New York, New York, United States, 10065

Contacts

Erin Bange, MD, MSCE

646-422-4680

Memorial Sloan Kettering Nassau (All Protocol Activities)

Recruiting

Uniondale, New York, United States, 11553

Contacts

Erin Bange, MD, MSCE

646-422-4680

More Information

Sponsor

Memorial Sloan Kettering Cancer Center

Last update posted

Jul 31, 2026

Last verified

Jul, 2026

Keywords

  • Telehealth
  • Cancer Care at Home
  • 25-055

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center on 2026-07-31.